Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
This brief overview contrasts index and target date retirement funds, outlining core differences and practical tips to help you choose the right option.
25,442 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Hyperion DeFi’s Q1 2026 results shed light on how this multi-chain protocol monetizes activities across lending, liqu...
Tech chipmakers pull back Friday after a brisk rally, with Intel leading declines and Nvidia slipping ahead of earnings.
As Gen Z joins more roles in 2026, execs confront a surge of stereotypes that threaten hiring, product strategy, and ...
A seasoned journalist spends a year letting AI handle routine work, finding strong productivity gains but ongoing rel...
Arm is catching renewed investor attention as data-center demand for energy-efficient CPUs grows. Analysts say arm’s ...
A disciplined $100/month Bitcoin plan started in 2015 would have yielded about $632,000 by May 2026, according to Coi...
Honda is shifting strategy, moving toward hybrids while still pursuing a carbon-neutral future. This pivot changes ho...
The House passed an amended ROAD to Housing Act, striking the seven-year selloff for new BTR communities while keepin...
Lucky To Live Here Realty is joining SERHANT.'s Long Island push, bringing a $1B+ track record to the brokerage. The ...
Fannie Mae updates its crypto mortgage framework with a 250% collateral requirement, reshaping how crypto assets can ...
Qualcomm surges 12%, Skyworks rallies 9%, and Qorvo climbs 7% as a narrowing set of mobile-chip winners outpaces broa...